Natco Pharma (India) Price History

NATCOPHARM   1,376  38.05  2.84%   
Below is the normalized historical share price chart for Natco Pharma Limited extending back to January 01, 1996. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Natco Pharma stands at 1,376, as last reported on the 1st of December, with the highest price reaching 1,384 and the lowest price hitting 1,340 during the day.
200 Day MA
1.2 K
50 Day MA
1.4 K
Beta
0.519
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Natco Stock, it is important to understand the factors that can impact its price. Natco Pharma Limited has Sharpe Ratio of -0.0951, which conveys that the firm had a -0.0951% return per unit of risk over the last 3 months. Natco Pharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Natco Pharma's Standard Deviation of 1.7, mean deviation of 1.36, and Risk Adjusted Performance of (0.06) to check out the risk estimate we provide.
  
As of now, Natco Pharma's Total Stockholder Equity is increasing as compared to previous years. The Natco Pharma's current Liabilities And Stockholders Equity is estimated to increase to about 72.5 B, while Common Stock Shares Outstanding is projected to decrease to under 176.8 M. . Natco Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0951

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsNATCOPHARM

Estimated Market Risk

 1.67
  actual daily
14
86% of assets are more volatile

Expected Return

 -0.16
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.1
  actual daily
0
Most of other assets perform better
Based on monthly moving average Natco Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Natco Pharma by adding Natco Pharma to a well-diversified portfolio.
Price Book
3.4457
Enterprise Value Ebitda
8.749
Price Sales
5.3983
Shares Float
83.8 M
Dividend Share
1.25

Natco Pharma Stock Price History Chart

There are several ways to analyze Natco Stock price data. The simplest method is using a basic Natco candlestick price chart, which shows Natco Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 12, 20241591.09
Lowest PriceOctober 25, 20241290.47

Natco Pharma December 1, 2024 Stock Price Synopsis

Various analyses of Natco Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Natco Stock. It can be used to describe the percentage change in the price of Natco Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Natco Stock.
Natco Pharma Price Rate Of Daily Change 1.03 
Natco Pharma Price Daily Balance Of Power 0.87 
Natco Pharma Price Action Indicator 32.48 

Natco Pharma December 1, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Natco Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Natco Pharma intraday prices and daily technical indicators to check the level of noise trading in Natco Stock and then apply it to test your longer-term investment strategies against Natco.

Natco Stock Price History Data

The price series of Natco Pharma for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 300.62 with a coefficient of variation of 5.63. The daily prices for the period are spread out with arithmetic mean of 1428.94. The median price for the last 90 days is 1407.44. The company underwent 5:1 stock split on 26th of November 2015. Natco Pharma Limited issued dividends to stockholders on 2024-11-27.
OpenHighLowCloseVolume
12/01/2024
 1,348  1,384  1,340  1,376 
11/29/2024 1,348  1,384  1,340  1,376  767,917 
11/28/2024 1,369  1,371  1,332  1,337  496,711 
11/27/2024 1,363  1,376  1,348  1,351  441,750 
11/26/2024 1,372  1,377  1,349  1,354  419,923 
11/25/2024 1,376  1,380  1,354  1,363  572,166 
11/22/2024 1,378  1,385  1,352  1,356  361,884 
11/21/2024 1,363  1,387  1,360  1,373  536,416 
11/20/2024 1,363  1,363  1,363  1,363  1.00 
11/19/2024 1,360  1,386  1,353  1,363  593,011 
11/18/2024 1,387  1,390  1,350  1,354  630,359 
11/14/2024 1,371  1,425  1,371  1,375  1,205,234 
11/13/2024 1,395  1,432  1,359  1,365  2,009,833 
11/12/2024 1,400  1,448  1,376  1,389  2,277,316 
11/11/2024 1,406  1,423  1,387  1,394  351,695 
11/08/2024 1,438  1,438  1,399  1,406  271,053 
11/07/2024 1,446  1,459  1,421  1,430  382,225 
11/06/2024 1,431  1,448  1,417  1,446  361,555 
11/05/2024 1,407  1,426  1,401  1,420  273,870 
11/04/2024 1,430  1,430  1,394  1,407  275,800 
11/01/2024 1,435  1,438  1,415  1,425  146,976 
10/31/2024 1,381  1,412  1,363  1,401  343,836 
10/30/2024 1,345  1,389  1,344  1,381  370,163 
10/29/2024 1,324  1,355  1,314  1,340  367,606 
10/28/2024 1,294  1,335  1,281  1,322  404,235 
10/25/2024 1,346  1,352  1,286  1,290  510,970 
10/24/2024 1,319  1,350  1,315  1,339  232,758 
10/23/2024 1,311  1,353  1,309  1,319  413,965 
10/22/2024 1,372  1,383  1,317  1,327  574,707 
10/21/2024 1,403  1,407  1,367  1,372  372,991 
10/18/2024 1,390  1,402  1,364  1,397  412,879 
10/17/2024 1,402  1,406  1,375  1,388  353,345 
10/16/2024 1,390  1,410  1,385  1,397  445,611 
10/15/2024 1,423  1,431  1,362  1,388  1,034,278 
10/14/2024 1,442  1,447  1,413  1,419  507,416 
10/11/2024 1,434  1,444  1,425  1,435  366,413 
10/10/2024 1,479  1,480  1,432  1,436  880,333 
10/09/2024 1,432  1,483  1,430  1,473  1,570,069 
10/08/2024 1,407  1,430  1,387  1,425  989,486 
10/07/2024 1,361  1,411  1,349  1,400  2,566,500 
10/04/2024 1,359  1,385  1,344  1,352  662,090 
10/03/2024 1,386  1,397  1,358  1,361  681,553 
10/01/2024 1,418  1,423  1,395  1,399  400,796 
09/30/2024 1,422  1,447  1,401  1,418  824,831 
09/27/2024 1,384  1,421  1,384  1,412  926,077 
09/26/2024 1,424  1,424  1,375  1,381  842,506 
09/25/2024 1,414  1,432  1,403  1,415  637,436 
09/24/2024 1,440  1,455  1,405  1,413  957,539 
09/23/2024 1,489  1,499  1,433  1,439  1,302,302 
09/20/2024 1,514  1,526  1,469  1,479  1,026,936 
09/19/2024 1,549  1,558  1,488  1,513  914,903 
09/18/2024 1,551  1,560  1,519  1,541  766,070 
09/17/2024 1,575  1,581  1,556  1,560  330,375 
09/16/2024 1,590  1,592  1,555  1,576  472,054 
09/13/2024 1,603  1,614  1,570  1,581  622,007 
09/12/2024 1,603  1,637  1,564  1,591  1,334,511 
09/11/2024 1,553  1,622  1,548  1,590  2,207,302 
09/10/2024 1,555  1,584  1,534  1,544  762,007 
09/09/2024 1,563  1,563  1,521  1,545  391,021 
09/06/2024 1,561  1,576  1,530  1,558  538,961 
09/05/2024 1,566  1,596  1,548  1,554  857,102 

About Natco Pharma Stock history

Natco Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Natco is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Natco Pharma Limited will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Natco Pharma stock prices may prove useful in developing a viable investing in Natco Pharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding179.5 M176.8 M
Net Income Applicable To Common Shares8.2 B4.4 B

Natco Pharma Quarterly Net Working Capital

30.51 Billion

Natco Pharma Stock Technical Analysis

Natco Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Natco Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Natco Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

Natco Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Natco Pharma's price direction in advance. Along with the technical and fundamental analysis of Natco Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Natco to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Natco Stock analysis

When running Natco Pharma's price analysis, check to measure Natco Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Natco Pharma is operating at the current time. Most of Natco Pharma's value examination focuses on studying past and present price action to predict the probability of Natco Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Natco Pharma's price. Additionally, you may evaluate how the addition of Natco Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance